1. Glucagon-like peptide-1 receptor agonists in neoplastic diseases
   Lisan Ji et al, 2024, Frontiers in Endocrinology CrossRef
2. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
   Sho-ichi Yamagishi et al, 2015, Cardiovascular Diabetology CrossRef
3. Modulation of myocardial injury and collagen deposition following ischaemia–reperfusion by linagliptin and liraglutide, and both together
   Xianwei Wang et al, 2016, Clinical Science CrossRef
4. Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
   Samson Mathews Samuel et al, 2022, Biomolecules CrossRef
5. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis
   Song Chen et al, 2016, Neuroscience Letters CrossRef
6. Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide
   Cheng-Yen Tsai et al, 2015, International Journal of Cardiology CrossRef
7. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
   Lin Zhu et al, 2014, Cardiovascular Diabetology CrossRef
8. Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction
   Aysegul Durak et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
9. Myocardial glucotoxicity: Mechanisms and potential therapeutic targets
   Sylvain Battault et al, 2020, Archives of Cardiovascular Diseases CrossRef
10. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges
    Md Abdul Alim Al-Bari et al, 2024, World Journal of Diabetes CrossRef
11. Advanced Glycation End Products: New Clinical and Molecular Perspectives
    Juan Salazar et al, 2021, International Journal of Environmental Research and Public Health CrossRef
12. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
    Dilara Kiran et al, 2016, Seminars in Immunopathology CrossRef
13. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products
    Shuang-Shuang Zhang et al, 2017, Biochemical and Biophysical Research Communications CrossRef